This trend may be partially explained by the fact that BL reconstructions are often chosen by patients with genetic or familial risk factors, such as BRCA1 or BRCA2 mutations, which are linked to an earlier onset of breast cancer [16,28,29,30]. This evidence concerns the gene BRCA2 and breast cancer.